Honduras vs Pakistan: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Honduras
86.0%
in 2025
Pakistan
86.0%
in 2025
Honduras rank
90th
Pakistan rank
90th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Honduras
- Pakistan
How they compare
Honduras currently reports 86.0% against 86.0% in Pakistan, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Pakistan ahead.
Honduras ranks 90th and Pakistan ranks 90th of 192 countries.
Honduras has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Honduras | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 83.7% | 53.8% | 29.9% | Honduras |
| 2020s | 87.8% | 84.8% | 3.0% | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Honduras or Pakistan?
- Honduras, at 86.0% against 86.0% in Pakistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Honduras and Pakistan?
- 0.0%, with Honduras ahead.
- How many years of comparable data are there for Honduras and Pakistan?
- 18 years are reported by both, from 2008 to 2025.
- How do Honduras and Pakistan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Honduras ranks 90th and Pakistan ranks 90th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.